By Owen Corbin, Global Investigator Network Lead, IQVIA Virtual Trials
No. In fact, it may put them in higher demand.
There is no question that decentralized clinical trials are transforming the clinical research environment. This patient-centric approach to research, which leverages telemedicine, home health visits and digital devices to treat patients remotely, is making it possible for sponsors to engage with a more diverse patient population, accelerate recruiting, and lower the burden of trial participation.
It’s a win-win for patients and sponsors, however some investigator site leaders worry that this new paradigm might put them out of business. If research participants no longer attend site visits, they wonder, what is the point of the site in clinical trials?
Investigators need not worry. Demand for sites in clinical research is not slipping away. As long as they are willing to adapt to this new approach of interacting remotely with the patient, virtual trials may even help them grow and participate more effectively in research.